Brief: Incannex Submits IND Application To The US FDA For IHL-42X For Obstructive Sleep Apnoea
21/07/2023 14:14
July 21 (Reuters) - Incannex Healthcare Ltd IHL.AX :
* INCANNEX SUBMITS IND APPLICATION TO THE US FDA FOR IHL-42X
FOR
OBSTRUCTIVE SLEEP APNOEA
Source text for Eikon: ID:nGNX53JH8b
Further company coverage: IHL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsBrief: Incannex Healthcare Says Computershare To Be Appointed As US Transfer Agent
Brief: Incannex Healthcare Says Federal Court Of Australia Approved Proposed Schemes Of Arrangement Between Incannex And Its Shareholders
Australia's Incannex up as shareholders in favour of US redomicile
Brief: Incannex Healthcare Will Prepare FDA Ind Application PSI-Gad
Brief: Review Of Ind Application For Ihl-42X By Us FDA Has Been Completed Clinical Trial For Patients With Obstructive Sleep Apnoea May Proceed